aiqbench analysis
This study applies contrastive learning to align neural dynamics between mice and humans, successfully using cross-species representations to retrospectively track drug efficacy in neurological disorders. By organizing data by biological state rather than species, the framework distinguishes conserved disease features from experimental noise, offering a robust method for improving preclinical model validation.
Cross-species representation learning aligns mouse and human neural dynamics and tracks clinical drug efficacy
arXiv:2610.11222v1 Announce Type: cross Abstract: Preclinical models poorly predict human drug efficacy, particularly in neurological disorders. Neural activity offers a uniquely rich source of translational information because it captures high-dimensional variation in nervous-system function that can be measured in both animals and humans. However, its high dimensionality makes it difficult to distinguish conserved disease-related features from variation arising from species, recording modality and experimental context. Here, we test whether shared neural dynamics can be identified directly from electrophysiology data by learning representations organized by biological state rather than species. We develop a dual-rule contrastive learning framework that aligns corresponding mouse and human states while preserving separation between distinct phenotypes. This framework recovered conserved sensory-response structure across species and, in epilepsy, resolved distinct relationships between three mouse models and heterogeneous human patient populations. When treated animals were projected into a frozen cross-species representation, drug-induced movement towards the human-aligned healthy state retrospectively tracked known clinical efficacy across ten model-drug combinations including a disease-specific detrimental effect. The framework also identified shared disease-associated neural dynamics between Fmr1-knockout mice and human 16p11.2 copy-number variant carriers despite differences in genetic aetiology and recording modality. Together, these findings show the potential of cross-species neural representation learning to map heterogeneous human disease onto experimentally tractable preclinical states and assess whether interventions restore human-relevant circuit function.
Abstract:Preclinical models poorly predict human drug efficacy, particularly in neurological disorders. Neural activity offers a uniquely rich source of translational information because it captures high-dimensional variation in nervous-system function that can be measured in both animals and humans. However, its high dimensionality makes it difficult to distinguish conserved disease-related features from variation arising from species, recording modality and experimental context. Here, we test whether shared neural dynamics can be identified directly from electrophysiology data by learning representations organized by biological state rather than species. We develop a dual-rule contrastive learning framework that aligns corresponding mouse and human states while preserving separation between distinct phenotypes. This framework recovered conserved sensory-response structure across species and, in epilepsy, resolved distinct relationships between three mouse models and heterogeneous human patient populations. When treated animals were projected into a frozen cross-species representation, drug-induced movement towards the human-aligned healthy state retrospectively tracked known clinical efficacy across ten model-drug combinations including a disease-specific detrimental effect. The framework also identified shared disease-associated neural dynamics between Fmr1-knockout mice and human 16p11.2 copy-number variant carriers despite differences in genetic aetiology and recording modality. Together, these findings show the potential of cross-species neural representation learning to map heterogeneous human disease onto experimentally tractable preclinical states and assess whether interventions restore human-relevant circuit function.
Quantitative Methods (q-bio.QM); Machine Learning (cs.LG); Neurons and Cognition (q-bio.NC)
arXiv:2610.11222 [q-bio.QM]
(or arXiv:2610.11222v1 [q-bio.QM] for this version)
https://doi.org/10.48550/arXiv.2610.11222 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 313 words
Related coverage
Language as the Interface: Foundation-Model Contrastive Learning Links Transcriptomes and Electrophysiology
arXiv · Sep 30, 2026
The J-Space Debate, Agent Swarms, and Pacing Frontier AI - Digital Minds Newsletter #4
LessWrong · Sep 18, 2026

Neuroscience Institute researchers use AI to model brain’s image sense.
Quantum Zeitgeist · Aug 30, 2026

Glial cells’ 3D ‘maps’ reveal key to brain development
Quantum Zeitgeist · Sep 3, 2026